Use of protein antigens for early serological diagnosis of leprosy

Clinical and Vaccine Immunology

Volumn 14, Issue 11, 2007, Pages 1400-1408

  Duthie, Malcolm S ^a   Goto, Wakako ^a   Ireton, Greg C ^a   Reece, Stephen T ^a   Cardoso, Ludimila P V ^b   Martelli, Celina M T ^b   Stefani, Mariane M A ^b   Nakatani, Maria ^c   De Jesus, Robson Crusue ^c   Netto, Eduardo M ^c   Balagon, Ma V F ^d   Tan, Esterlina ^d   Gelber, Robert H ^d   Maeda, Yumi ^e   Makino, Masahiko ^e   Hoft, Dan ^f   Reed, Steven G ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d Leonard Wood Memorial Center for Leprosy Research Philippines   (Philippines)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BCG VACCINE; GENE PRODUCT; IMMUNOGLOBULIN G; ML0405 PROTEIN; ML2331 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL TRANSMISSION; BRAZIL; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GENE CONSTRUCT; GENE FUSION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNIZATION; JAPAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; NUCLEOTIDE SEQUENCE; PHILIPPINES; PRIORITY JOURNAL; SEASHORE; SERODIAGNOSIS; SERUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHILD; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; RECOMBINANT FUSION PROTEINS;

EID: 37349045630     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00299-07     Document Type: Article

References (28)

1. Anderson, H., B. Stryjewska, B. L. Boyanton, and M. R. Schwartz. 2007. Hansen disease in the United States in the 21st century: a review of the literature. Arch. Pathol. Lab. Med. 131:982-986.
2. Bakker, M. I., M. Hatta, A. Kwenang, P. Van Mosseveld, W. R. Faber, P. R. Klatser, and L. Oskam. 2006. Risk factors for developing leprosy a population-based cohort study in Indonesia. Lepr. Rev. 77:48-61.
3. Buhrer, S. S., H. L. Smits, G. C. Gussenhoven, C. W. van Ingen, and P. R. Klatser. 1998. A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am. J. Trop. Med. Hyg. 58:133-136.
4. Buhrer-Sekula, S., H. L. Smits, G. C. Gussenhoven, J. van Leeuwen, S. Amador, T. Fujiwara, P. R. Klatser, and L. Oskam. 2003. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J. Clin. Microbiol. 41:1991-1995.
5. Cartel, J. L., S. Chanteau, J. P. Boutin, R. Plichart, P. Richez, J. F. Roux, and J. H. Grosset. 1990. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands. Int. J. Lepr. Other Mycobact. Dis. 58:512-517.
6. Chanteau, S., P. Glaziou, C. Plichart, P. Luquiaud, R. Plichart, J. F. Faucher, and J. L. Cartel. 1993. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Int. J. Lepr. Other Mycobact. Dis. 61:533-541.
7. Cho, S. N., R. V. Cellona, L. G. Villahermosa, T. T. Fajardo, Jr., M. V. Balagon, R. M. Abalos, E. V. Tan, G. P. Walsh, J. D. Kim, and P. J. Brennen. 2001. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin. Diagn. Lab. Immunol. 8:138-142.
8. Cho, S. N, D. L. Yanagihara, S. W. Hunter, R. H. Gelber, and P. J. Brennen. 1983. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect. Immun. 41:1077-1083.
9. Costa, M. B., P. F. Cavalcanti Neto, C. M. Martelli, M. M. Stefani, J. P. Maceira, M. K. Gomes, A. P. Schettini, P. F. Rebello, P. E. Pignataro, E. S. Ueda, K. Narahashi, and D. M. Scollard. 2001. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study. Int. J. Lepr. Other Mycobact. Dis. 69:177-186.
10. Deps, P. D., B. V. Guedes, J. Bucker Filho, M. K. Andreatta, R. S. Marcari, and L. C. Rodrigues. 2006. Characteristics of known leprosy contact in a high endemic area in Brazil. Lepr. Rev. 77:34-40.
11. Douglas, J. T., R. V. Cellona, T. T. Fajardo, Jr., R. M. Abalos, M. V. Balagon, and P. R. Klatser. 2004. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clin. Diagn. Lab. Immunol. 11:897-900.
12. Fine, P. E., J. A. Sterne, J. M. Ponnighaus, L. Bliss, J. Saui, A. Chihana, M. Munthali, and D. K. Warndorff. 1997. Household and dwelling contact as risk factors for leprosy in northern Malawi. Am. J. Epidemiol. 146:91-102.
13. Flower, C., D. Gaskin, and S. Marquez. 2007. A case of recurrent rash and leg numbness mimicking systemic rheumatic disease: the occurrence of leprosy in a nonendemic area. J. Clin. Rheumatol. 13:143-145.
14. Gonzalez-Abreu, E., J. A. Pon, P. Hernadez, J. Rodriguez, E. Mendoza, M. Hernandez, E. Cuevas, and A. B. Gonzalez. 1996. Serological reactivity to a synthetic analog of phenolic glycolipid I and early detection of leprosy in an area of low endemicity. Lepr. Rev. 67:4-12.
15. Hussain, R., S. Jamil, A. Kifayet, F. Firdausi, H. M. Dockrell, S. Lucas, and R. Hasan. 1990. Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy. Int. J. Lepr. Other Mycobact. Dis. 58:491-502.
16. Lockwood, D. N., and A. J. Reid. 2001. The diagnosis of leprosy is delayed in the United Kingdom. QJM 94:207-212.
17. Lockwood, D. N., and S. Suneetha. 2005. Leprosy: too complex a disease for a simple elimination paradigm. Bull. W. H. O. 83:230-235.
18. Meima, A., J. H. Richardus, and J. D. Habbema. 2004. Trends in leprosy case detection worldwide since 1985. Lepr. Rev. 75:19-33.
19. Oskam, L., E. Slim, and S. Buhrer-Sekula. 2003. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr. Rev. 74:196-205.
20. Reece, S. T., G. Ireton, R. Mohamath, J. Guderian, W. Goto, R. Gelber, N. Groathouse, J. Spencer, P. Brennan, and S. G. Reed. 2006. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin. Vaccine Immunol. 13:333-340.
21. Ridley, D. S., and W. H. Jopling. 1966. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. Other Mycobact. Dis. 34:255-273.
22. Roche, P. W., W. J. Britton, S. S. Failbus, D. Williams, H. M. Pradhan, and W. J. Theuvenet. 1990. Operational value of serological measurements in multibacillary leprosy patients: clinical and bacteriological correlates of antibody responses. Int. J. Lepr. Other Mycobact. Dis. 58:480-490.
23. Roche, P. W., S. S. Failbus, W. J. Britton, and R. Cole. 1999. Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-1 antibodies detected by ELISA and "dipstick" methods. Int. J. Lepr. Other Mycobact. Dis. 67:279-286.
24. Scollard, D. M. 2004. Classification of leprosy: a full color spectrum, or black and white? Int. J. Lepr. Other Mycobact. Dis. 72:166-168.
25. Van Buynder, P., J. Eccleston, J. Leese, and D. N. Lockwood. 1999. Leprosy in England and Wales. Commun. Dis. Public Health 2:119-121.
26. WHO. 2005. Global leprosy situation, 2005. Wkly. Epidemiol. Rec. 80:289-295.
27. WHO. 2007. Global leprosy situation, 2007. Wkly. Epidemiol. Rec. 82:225-232.
28. Young, D. B., and T. M. Buchanan. 1983. A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science 221:1057-1059.